DNA Probebased DiagnosticUnited States Market Size, Industry Trends, and Statistics Report

DNA Probe-based Diagnostic-United States Market Status and Trend Report 2013-2023

Report ID: MIReports 2000 | Number of pages: 146 | Publish Date: Mar 2019 | Category: Medical Devices and Consumables 
Report Summary

DNA Probe-based Diagnostic-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on DNA Probe-based Diagnostic industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of DNA Probe-based Diagnostic 2013-2017, and development forecast 2018-2023
Main market players of DNA Probe-based Diagnostic in United States, with company and product introduction, position in the DNA Probe-based Diagnostic market
Market status and development trend of DNA Probe-based Diagnostic by types and applications
Cost and profit status of DNA Probe-based Diagnostic, and marketing status
Market growth drivers and challenges

The report segments the United States DNA Probe-based Diagnostic market as:

United States DNA Probe-based Diagnostic Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States DNA Probe-based Diagnostic Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA Probes-Based Products 
Direct Detection of Target Sequence 
Nucleic Acid Amplification 
Gene Detection Using DNA Chips 
Gene Detection by DNA Sequencing

United States DNA Probe-based Diagnostic Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Infectious disease testing 
Cancer testing

United States DNA Probe-based Diagnostic Market: Players Segment Analysis (Company and Product introduction, DNA Probe-based Diagnostic Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories 
F. Hoffmann La Roche 
GE Healthcare 
Thermo Fisher Scientific 
BD 
Biogenex 
bioMerieux 
Biolegio 
Luminex 
MP Biomedicals

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Interested in this report?
Get your sample now!
Download Sample 
Table of Contents
Chapter 1 Overview of DNA Probe-based Diagnostic
    1.1 Definition of DNA Probe-based Diagnostic in This Report
    1.2 Commercial Types of DNA Probe-based Diagnostic
        1.2.1 DNA Probes-Based Products 
        1.2.2 Direct Detection of Target Sequence 
        1.2.3 Nucleic Acid Amplification 
        1.2.4 Gene Detection Using DNA Chips 
        1.2.5 Gene Detection by DNA Sequencing
    1.3 Downstream Application of DNA Probe-based Diagnostic
        1.3.1 Infectious disease testing 
        1.3.2 Cancer testing
    1.4 Development History of DNA Probe-based Diagnostic
    1.5 Market Status and Trend of DNA Probe-based Diagnostic 2013-2023
        1.5.1 United States DNA Probe-based Diagnostic Market Status and Trend 2013-2023
        1.5.2 Regional DNA Probe-based Diagnostic Market Status and Trend 2013-2023
Chapter 2 United States Market Status and Forecast by Regions
    2.1 Market Status of DNA Probe-based Diagnostic in United States 2013-2017
    2.2 Consumption Market of DNA Probe-based Diagnostic in United States by Regions
        2.2.1 Consumption Volume of DNA Probe-based Diagnostic in United States by Regions
        2.2.2 Revenue of DNA Probe-based Diagnostic in United States by Regions
    2.3 Market Analysis of DNA Probe-based Diagnostic in United States by Regions
        2.3.1 Market Analysis of DNA Probe-based Diagnostic in New England 2013-2017
        2.3.2 Market Analysis of DNA Probe-based Diagnostic in The Middle Atlantic 2013-2017
        2.3.3 Market Analysis of DNA Probe-based Diagnostic in The Midwest 2013-2017
        2.3.4 Market Analysis of DNA Probe-based Diagnostic in The West 2013-2017
        2.3.5 Market Analysis of DNA Probe-based Diagnostic in The South 2013-2017
        2.3.6 Market Analysis of DNA Probe-based Diagnostic in Southwest 2013-2017
    2.4 Market Development Forecast of DNA Probe-based Diagnostic in United States 2018-2023
        2.4.1 Market Development Forecast of DNA Probe-based Diagnostic in United States 2018-2023
        2.4.2 Market Development Forecast of DNA Probe-based Diagnostic by Regions 2018-2023
Chapter 3 United States Market Status and Forecast by Types
    3.1 Whole United States Market Status by Types
        3.1.1 Consumption Volume of DNA Probe-based Diagnostic in United States by Types
        3.1.2 Revenue of DNA Probe-based Diagnostic in United States by Types
    3.2 United States Market Status by Types in Major Countries
        3.2.1 Market Status by Types in New England
        3.2.2 Market Status by Types in The Middle Atlantic
        3.2.3 Market Status by Types in The Midwest
        3.2.4 Market Status by Types in The West
        3.2.5 Market Status by Types in The South
        3.2.6 Market Status by Types in Southwest
    3.3 Market Forecast of DNA Probe-based Diagnostic in United States by Types
Chapter 4 United States Market Status and Forecast by Downstream Industry
    4.1 Demand Volume of DNA Probe-based Diagnostic in United States by Downstream Industry
    4.2 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Major Countries
        4.2.1 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in New England
        4.2.2 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The Middle Atlantic
        4.2.3 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The Midwest
        4.2.4 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The West
        4.2.5 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The South
        4.2.6 Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Southwest
    4.3 Market Forecast of DNA Probe-based Diagnostic in United States by Downstream Industry
Chapter 5 Market Driving Factor Analysis of DNA Probe-based Diagnostic
    5.1 United States Economy Situation and Trend Overview
    5.2 DNA Probe-based Diagnostic Downstream Industry Situation and Trend Overview
Chapter 6 DNA Probe-based Diagnostic Market Competition Status by Major Players in United States
    6.1 Sales Volume of DNA Probe-based Diagnostic in United States by Major Players
    6.2 Revenue of DNA Probe-based Diagnostic in United States by Major Players
    6.3 Basic Information of DNA Probe-based Diagnostic by Major Players
        6.3.1 Headquarters Location and Established Time of DNA Probe-based Diagnostic Major Players
        6.3.2 Employees and Revenue Level of DNA Probe-based Diagnostic Major Players
    6.4 Market Competition News and Trend
        6.4.1 Merger, Consolidation or Acquisition News
        6.4.2 Investment or Disinvestment News
        6.4.3 New Product Development and Launch
Chapter 7 DNA Probe-based Diagnostic Major Manufacturers Introduction and Market Data
    7.1 Abbott Laboratories 
        7.1.1 Company profile
        7.1.2 Representative DNA Probe-based Diagnostic Product
        7.1.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Abbott Laboratories 
    7.2 F. Hoffmann La Roche 
        7.2.1 Company profile
        7.2.2 Representative DNA Probe-based Diagnostic Product
        7.2.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of F. Hoffmann La Roche 
    7.3 GE Healthcare 
        7.3.1 Company profile
        7.3.2 Representative DNA Probe-based Diagnostic Product
        7.3.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of GE Healthcare 
    7.4 Thermo Fisher Scientific 
        7.4.1 Company profile
        7.4.2 Representative DNA Probe-based Diagnostic Product
        7.4.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific 
    7.5 BD 
        7.5.1 Company profile
        7.5.2 Representative DNA Probe-based Diagnostic Product
        7.5.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of BD 
    7.6 Biogenex 
        7.6.1 Company profile
        7.6.2 Representative DNA Probe-based Diagnostic Product
        7.6.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biogenex 
    7.7 bioMerieux 
        7.7.1 Company profile
        7.7.2 Representative DNA Probe-based Diagnostic Product
        7.7.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of bioMerieux 
    7.8 Biolegio 
        7.8.1 Company profile
        7.8.2 Representative DNA Probe-based Diagnostic Product
        7.8.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biolegio 
    7.9 Luminex 
        7.9.1 Company profile
        7.9.2 Representative DNA Probe-based Diagnostic Product
        7.9.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Luminex 
    7.10 MP Biomedicals
        7.10.1 Company profile
        7.10.2 Representative DNA Probe-based Diagnostic Product
        7.10.3 DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of MP Biomedicals
Chapter 8 Upstream and Downstream Market Analysis of DNA Probe-based Diagnostic
    8.1 Industry Chain of DNA Probe-based Diagnostic
    8.2 Upstream Market and Representative Companies Analysis
    8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of DNA Probe-based Diagnostic
    9.1 Cost Structure Analysis of DNA Probe-based Diagnostic
    9.2 Raw Materials Cost Analysis of DNA Probe-based Diagnostic
    9.3 Labor Cost Analysis of DNA Probe-based Diagnostic
    9.4 Manufacturing Expenses Analysis of DNA Probe-based Diagnostic
Chapter 10 Marketing Status Analysis of DNA Probe-based Diagnostic
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Reference


List of Tables

    Table Advantage and Disadvantage of DNA Probes-Based Products 
    Table Advantage and Disadvantage of Direct Detection of Target Sequence 
    Table Advantage and Disadvantage of Nucleic Acid Amplification 
    Table Advantage and Disadvantage of Gene Detection Using DNA Chips 
    Table Advantage and Disadvantage of Gene Detection by DNA Sequencing
    Table Consumption Volume of DNA Probe-based Diagnostic in United States by Regions 2013-2017
    Table Revenue of DNA Probe-based Diagnostic in United States by Regions 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic in United States by Regions 2018-2023
    Table Revenue of DNA Probe-based Diagnostic in United States by Regions 2018-2023
    Table Consumption Volume of DNA Probe-based Diagnostic in United States by Types 2013-2017
    Table Revenue of DNA Probe-based Diagnostic in United States by Types 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic by Types in New England 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic by Types in The Middle Atlantic 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic by Types in The Midwest 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic by Types in The West 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic by Types in The South 2013-2017
    Table Consumption Volume of DNA Probe-based Diagnostic by Types in Southwest 2013-2017
    Table Consumption Volume Forecast of DNA Probe-based Diagnostic in United States by Types 2018-2023
    Table Revenue Forecast of DNA Probe-based Diagnostic in United States by Types 2018-2023
    Table Demand Volume of DNA Probe-based Diagnostic in United States by Downstream Industry 2013-2017
    Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in New England 2013-2017
    Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The Middle Atlantic 2013-2017
    Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The Midwest 2013-2017
    Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The West 2013-2017
    Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in The South 2013-2017
    Table Demand Volume of DNA Probe-based Diagnostic by Downstream Industry in Southwest 2013-2017
    Table Demand Volume Forecast of DNA Probe-based Diagnostic in United States by Downstream Industry 2018-2023
    Table Sales Volume of DNA Probe-based Diagnostic in United States by Major Players 2013-2017
    Table Revenue of DNA Probe-based Diagnostic in United States by Major Players 2013-2017
    Table Headquarters Location and Established Time of DNA Probe-based Diagnostic Major Players
    Table Employees and Revenue Level of DNA Probe-based Diagnostic Major Players
    Table Representative DNA Probe-based Diagnostic Product One of Abbott Laboratories 
    Table Representative DNA Probe-based Diagnostic Product Two of Abbott Laboratories 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Abbott Laboratories  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of F. Hoffmann La Roche 
    Table Representative DNA Probe-based Diagnostic Product Two of F. Hoffmann La Roche 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of F. Hoffmann La Roche  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of GE Healthcare 
    Table Representative DNA Probe-based Diagnostic Product Two of GE Healthcare 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of GE Healthcare  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of Thermo Fisher Scientific 
    Table Representative DNA Probe-based Diagnostic Product Two of Thermo Fisher Scientific 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of BD 
    Table Representative DNA Probe-based Diagnostic Product Two of BD 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of BD  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of Biogenex 
    Table Representative DNA Probe-based Diagnostic Product Two of Biogenex 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biogenex  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of bioMerieux 
    Table Representative DNA Probe-based Diagnostic Product Two of bioMerieux 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of bioMerieux  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of Biolegio 
    Table Representative DNA Probe-based Diagnostic Product Two of Biolegio 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Biolegio  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of Luminex 
    Table Representative DNA Probe-based Diagnostic Product Two of Luminex 
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of Luminex  2013-2017
    Table Representative DNA Probe-based Diagnostic Product One of MP Biomedicals
    Table Representative DNA Probe-based Diagnostic Product Two of MP Biomedicals
    Table DNA Probe-based Diagnostic Sales, Revenue, Price and Gross Margin of MP Biomedicals 2013-2017